Approach to the patient with amiodarone-induced thyrotoxicosis

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 6, 2010, Pages 2529-2535

  Bogazzi, Fausto ^a   Bartalena, Luigi ^b   Martino, Enio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTITHROMBOCYTIC AGENT; GLUCOCORTICOID; IOPANOIC ACID; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; POTASSIUM PERCHLORATE; PREDNISONE; PROPYLTHIOURACIL; THIAMAZOLE; THIONAMIDE; ANTIARRHYTHMIC AGENT; BIOLOGICAL MARKER; DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

AGED; AMDIODARONE INDUCED THYROTOXICOSIS; AMIODARONE INDUCED THYROTOXICOSIS; APPETITE; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL PROTOCOL; COLOR ULTRASOUND FLOWMETRY; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; DRUG INDUCED DESTRUCTIVE THYROIDITIS; DRUG POTENTIATION; DRUG WITHDRAWAL; ECHOGRAPHY; EUTHYROIDISM; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HEART ARRHYTHMIA; HEART PALPITATION; HUMAN; INSOMNIA; IODINE INDUCED HYPERTHYROIDISM; MALE; NERVOUSNESS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; STEROID THERAPY; THYROTOXICOSIS; TREATMENT RESPONSE; URINARY EXCRETION; WEIGHT REDUCTION; CHEMICALLY INDUCED DISORDER; HEART ATRIUM FIBRILLATION; POSITRON EMISSION TOMOGRAPHY; REVIEW; THYROID FUNCTION TEST; THYROID GLAND;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; HUMANS; IODINE RADIOISOTOPES; MALE; POSITRON-EMISSION TOMOGRAPHY; TECHNETIUM TC 99M SESTAMIBI; THYROID FUNCTION TESTS; THYROID GLAND; THYROTOXICOSIS;

EID: 77954484535     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0180     Document Type: Article

References (47)

1. Martino E, Bartalena L, Bogazzi F, Braverman LE 2001 The effects of amiodarone on the thyroid. Endocr Rev 22:240-254
2. Martino E, Safran M, Aghini-Lombardi F, Rajatanavin R, Lenziardi M, Fay M, Pacchiarotti A, Aronin N, Macchia E, Haffajee C 1984 Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med 101:28-34 (Pubitemid 14088063)
3. Bartalena L, Wiersinga WM, Tanda ML, Bogazzi F, Piantanida E, Lai A, Martino E 2004 Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. Clin Endocrinol (Oxf) 61:494-502
4. Diehl LA, Romaldini JH, Graf H, Bartalena L, Martino E, Albino CC, Wiersinga WM 2006 Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey. Clin Endocrinol (Oxf) 65:433-438
5. Tanda ML, Piantanida E, Lai A, Liparulo G, Sassi L, Bogazzi F, Wiersinga WM, Braverman LE, Martino E, Bartalena L 2008 Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists. Clin Endocrinol (Oxf) 69:812-818
6. Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E 1996 Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab 81:2930-2933
7. Bogazzi F, Bartalena L, Dell'Unto E, Tomisti L, Rossi G, Pepe P, Tanda ML, Grasso L, Macchia E, Aghini-Lombardi F, Pinchera A, Martino E 2007 Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy. Clin Endocrinol (Oxf) 67:533-537
8. Eskes SA, Wiersinga WM 2009 Amiodarone and thyroid. Best Pract Res Clin Endocrinol Metab 23:735-751
9. Han TS, Williams GR, Vanderpump MP 2009 Benzofuran derivatives and the thyroid. Clin Endocrinol (Oxf) 70:2-13
10. Kurt IH, Yigit T, Karademir BM 2008 Atrial fibrillation due to late amiodarone-induced thyrotoxicosis. Clin Drug Invest 28:527-531
11. Basaria S, Cooper DS 2005 Amiodarone and the thyroid. Am J Med 118:706-714
12. Cohen-Lehman J, Dahl P, Danzi S, Klein I 2010 Effects of amiodarone therapy on thyroid function. Nat Rev Endocrinol 6:34-41
13. Bogazzi F, Bartalena L, Brogioni S, Mazzeo S, Vitti P, Burelli A, Bartolozzi C, Martino E 1997 Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 7:541-545
14. Eaton SE, Euinton HA, Newman CM, Weetman AP, Bennet WM 2002 Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin Endocrinol (Oxf) 56:33-38
15. Bogazzi F, Martino E, Dell'Unto E, Brogioni S, Cosci C, Aghini-Lombardi F, Ceccarelli C, Pinchera A, Bartalena L, Braverman LE 2003 Thyroid color flow Doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis. J Endocrinol Invest 26:635-640 (Pubitemid 37270694)
16. Erdogan MF, Güleç S, Tutar E, Båkal N, Erdogan G 2003 A step-wise approach to the treatment of amiodarone-induced thyrotoxicosis. Thyroid 13:205-209 (Pubitemid 36596718)
17. Piga M, Cocco MC, Serra A, Boi F, Loy M, Mariotti S 2008 The usefulness of 99mTc-sesta MIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. Eur J Endocrinol 159:423-429
18. Tanda ML, Bogazzi F, Martino E, Bartalena L 2008 Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis? Eur J Endocrinol 159:359-361
19. Pearce EN, Bogazzi F, Martino E, Brogioni S, Pardini E, Pellegrini G, Parkes AB, Lazarus JH, Pinchera A, Braverman LE 2003 The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease. Thyroid 13:643-648 (Pubitemid 36993559)
20. O'Sullivan AJ, Lewis M, Diamond T 2006 Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. Eur J Endocrinol 154:533-536
21. Martino E, Aghini-Lombardi F, Mariotti S, Lenziardi M, Baschieri L, Braverman LE, Pinchera A 1986 Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. J Endocrinol Invest 9:201-207
22. Franklyn JA, Gammage MD 2007 Treatment of amiodarone-associated thyrotoxicosis. Nat Clin Pract Endocrinol Metab 3:662-666
23. Bogazzi F, Bartalena L, Tomisti L, Rossi G, Tanda ML, Dell'Unto E, Aghini-Lombardi F, Martino E 2007 Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. J Clin Endocrinol Metab 92:556-562
24. Bogazzi F, Tomisti L, Rossi G, Dell'Unto E, Pepe P, Bartalena L, Martino E 2009 Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study. J Clin Endocrinol Metab 94:3757-3762
25. Vanderpump MP 2009 Thyroid gland: use of glucocorticoids in amiodarone-induced thyrotoxicosis. Nat Rev Endocrinol 5:650-651
26. Dickstein G, Shechner C, Adawi F, Kaplan J, Baron E, Ish-Shalom S 1997 Lithium treatment in amiodarone-induced thyrotoxicosis. Am J Med 102:454-458
27. Chopra IJ, Baber K 2001 Use of oral cholecystographic agents in the treatment of amiodarone-induced hyperthyroidism. J Clin Endocrinol Metab 86:4707-4710
28. Bogazzi F, Bartalena L, Cosci C, Brogioni S, Dell'Unto E, Grasso L, Aghini-Lombardi F, Rossi G, Pinchera A, Braverman LE, Martino E 2003 Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. J Clin Endocrinol Metab 88:1999-2002
29. Bogazzi F, Miccoli P, Berti P, Cosci C, Brogioni S, Aghini-Lombardi F, Materazzi G, Bartalena L, Pinchera A, Braverman LE, Martino E 2002 Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy. Surgery 132:1114-1117; discussion 1118
30. Czarnywojtek A, Czepczynski R, Ruchala M, Wasko R, Zgorzalewicz- Stachowiak M, Szczepanek E, Zamyslowska H, Bartkowiak Z, Florek E, Sowinski J 2009 Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT). Neuroendocrinol Lett 30:209-214
31. Albino CC, Paz-Filho G, Graf H 2009 Recombinant human TSH as an adjuvant to radioiodine for the treatment of type 1 amiodarone-induced thyrotoxicosis (AIT). Clin Endocrinol (Oxf) 70:810-811
32. Bogazzi F, Tomisti L, Ceccarelli C, Martino E 2010 Recombinant human TSH as an adjuvant to radioiodine for the treatment of type 1 amiodarone-induced thyrotoxicosis: a cautionary note. Clin Endocrinol (Oxf) 72:133-134
33. Houghton SG, Farley DR, Brennan MD, van Heerden JA, Thompson GB, Grant CS 2004 Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience. World J Surg 28:1083-1087
34. Gough J, Gough IR 2006 Total thyroidectomy for amiodarone-associated thyrotoxicosis in patients with severe cardiac disease. World J Surg 30:1957-1961 (Pubitemid 44655798)
35. Berti P, Materazzi G, Bogazzi F, Ambrosini CE, Martino E, Miccoli P 2007 Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. Langenbecks' Arch Surg 392:709-713
36. Ryan LE, Braverman LE, Cooper DS, Ladenson PW, Kloos RT 2004 Can amiodarone be restarted after amiodarone-induced thyrotoxicosis? Thyroid 14:149-153
37. Roti E, Minelli R, Gardini E, Bianconi L, Braverman LE 1993 Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid. Arch Intern Med 153:886-892
38. Roti E, Bianconi L, De Chiara F, Minelli R, Tosi C, Gardini E, Salvi M, Braverman LE 1994 Thyroid ultrasonography in patients with a previous episode of amiodarone induced thyrotoxicosis. J Endocrinol Invest 17:259-262
39. Martino E, Aghini-Lombardi F, Lippi F, Baschieri L, Safran M, Braverman LE, Pinchera A 1985 Twenty-four hour radioactive iodine uptake in 35 patients with amiodarone associated thyrotoxicosis. J Nucl Med 26:1402-1407 (Pubitemid 16063020)
40. Wiersinga WM, Touber JL, Trip MD, van Royen EA 1986 Uninhibited thyroidal uptake of radioiodine despite iodine excess in amiodarone-induced hypothyroidism. J Clin Endocrinol Metab 63:485-491
41. Foresti V, Parisio E, Scolari N, Carini L, Lovagnini-Scher CA 1985 Amiodarone and antithyroid antibodies. Ann Intern Med 103:157-158
42. Monteiro E, Galvão-teles A, Santos ML, Mourão L, Correia MJ, Lopo Tuna J, Ribeiro C 1986 Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone. Br Med J (Clin Res Ed) 292:227-228 (Pubitemid 16161980)
43. Martino E, Macchia E, Aghini-Lombardi F, Antonelli A, Lenziardi M, Concetti R, Fenzi GF, Baschieri L, Pinchera A 1986 Is humoral thyroid autoimmunity relevant in amiodarone iodine-induced thyrotoxicosis (AIIT)? Clin Endocrinol (Oxf) 24 :627-633 (Pubitemid 16095716)
44. Rajatanavin R, Safran M, Stoller WA, Mordes JP, Braverman LE 1984 Five patients with iodine-induced hyperthyroidism. Am J Med 77:378-384
45. Wimpfheimer C, Stäubli M, Schädelin J, Studer H 1982 Prednisone in amiodarone-induced thyrotoxicosis. Br Med J (Clin Res Ed) 284:1835-1836
46. Bogazzi F, Dell'Unto E, Tanda ML, Tomisti L, Cosci C, Aghini-Lombardi F, Sardella C, Pinchera A, Bartalena L, Martino E 2006 Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis. J Endocrinol Invest 29: 694-699
47. Wiersinga WM 1997 Amiodarone and the thyroid. In Weetman AP, Grossman A, eds. Pharmacotherapeutics of the thyroid gland. Heidelberg: Springer; 227-287